1. "Biostatistics Service"
Formats
  1. Journal Article (3978)
  2. Meeting Abstract (2395)
  3. Research Letter (51)
  4. Conference Paper (37)
  5. Correspondence (26)
  6. Editorial (25)
  7. Review (21)
  8. Miscellaneous (14)
  9. Book Section (13)
  10. Book Whole (3)
  11. Guidelines (2)
Groups
  1. Biostatistics Service (6565)
  2. Epidemiology and Biostatistics (6565)
  3. Department of Medicine (3849)
  4. Solid Tumor Oncology Division (2571)
  5. Survivorship Research (2488)
  6. Surgery (2392)

More Groups

People
  1. Mithat Gonen (1028)
  2. Sean Devlin (601)
  3. Katherine Panageas (512)
  4. Sujata Patil (511)
  5. Sergio Giralt (465)
  6. Zhigang Zhang (427)

More People

Years
  1. 2025 (119)
  2. 2024 (362)
  3. 2023 (411)
  4. 2022 (407)
  5. 2021 (369)
  6. 2020 (394)

More Years

Publications
  1. Journal of Clinical Oncology (1058)
  2. Blood (432)
  3. Annals of Surgical Oncology (308)
  4. International Journal of Radiation Oncology, Biology, Physics (233)
  5. Clinical Cancer Research (195)
  6. Biology of Blood and Marrow Transplantation (174)

More Publications

Publishers
  1. American Society of Clinical Oncology (1124)
  2. Elsevier Inc. (930)
  3. Springer (625)
  4. American Society of Hematology (486)
  5. American Association for Cancer Research (430)
  6. Nature Publishing Group (311)

More Publishers

Results (6565)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alliance A031201: A phase III trial of enzalutamide (ENZ) versus enzalutamide, abiraterone, and prednisone (ENZ/AAP) for metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Morris, M. J.; Heller, G.; Bryce, A. H.; Armstrong, A. J.; Beltran, H.; Hahn, O. M.; McGary, E. C.; Mehan, P. T.; Goldkorn, A.; Roth, B. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Breast radiotherapy among ATM-mutation carriers
    Meeting Abstract

    Modlin, L. A.; Flynn, J.; Zhang, Z.; Mueller, B.; Khan, A. J.; Gillespie, E. F.; Cahlon, O.; McCormick, B.; Robson, M. E.; Powell, S. N.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study
    Meeting Abstract

    Mailankody, S.; Salcedo, M.; Tavitian, E.; Korde, N.; Lendvai, N.; Hassoun, H.; Lesokhin, A. M.; Lahoud, O. B.; Smith, E. L.; Hultcrantz, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer
    Meeting Abstract

    Liu, Y. L.; Zhou, Q.; Iasonos, A.; Filippova, O. T.; Chi, D.; Zivanovic, O.; Sonoda, Y.; Gardner, G. J.; Broach, V.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Opportunity for performance measurement: 30-day mortality following cancer surgeries across US hospitals
    Meeting Abstract

    Lipitz-Snyderman, A.; Lavery, J. A.; Bach, P.; Li, D. G.; Yang, A.; Strong, V. E.; Russo, A.; Panageas, K.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Impact of geriatric vulnerability on outcomes of older patients in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Flynn, J.; Jakubowski, A. A.; Shahrokni, A.; Dahi, P.; Perales, M. A.; Sanchez-Escamilla, M.; Tamari, R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine in patients with HER2 amplified salivary gland cancers (SGCs): Results from a phase II basket trial
    Meeting Abstract

    Li, B. T.; Shen, R.; Offin, M.; Buonocore, D. J.; Myers, M. L.; Venkatesh, A.; Razavi, P.; Ginsberg, M. S.; Ulaner, G. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Randomized phase II trial of adjuvant hepatic arterial infusion (HAI) + systemic FOLFIRI +/- panitumumab (Pmab) in patients with resected RAS wild type colorectal cancer hepatic metastases (CRLM)
    Meeting Abstract

    Kemeny, N. E.; Hauser, H.; Capanu, M.; Kingham, T. P.; Jarnagin, W. R.; DeMatteo, R. P.; Cercek, A.; Balachandran, V. P.; Drebin, J. A.; D'Angelica, M. I.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Kelly, C. M.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Qin, L. X.; Adamson, T.; Condy, M. M.; Biniakewitz, M.; Phelan, H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save